Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US OptionsDetailed Quotes
HCA250516P255000
- 5.70
- 0.000.00%
15min DelayClose Apr 30 16:00 ET
0.00High0.00Low
5.70Open5.70Pre Close0 Volume1 Open Interest255.00Strike Price0.00Turnover133.26%IV27.76%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier16DDays to Expiry5.70Extrinsic Value100Contract SizeAmericanOptions Type-0.1089Delta0.0019Gamma60.54Leverage Ratio-0.5570Theta-0.0177Rho-6.59Eff Leverage0.1345Vega
HCA Healthcare Newsroom
A Quick Look at Today's Ratings for HCA Healthcare(HCA.US), With a Forecast Between $355 to $390
HCA Healthcare Price Target Cut to $376.00/Share From $384.00 by RBC Capital
HCA Healthcare Is Maintained at Outperform by RBC Capital
HCA Healthcare Analyst Ratings
Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Edwards Lifesciences (EW) and Gilead Sciences (GILD)
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $370
Barclays Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $366
RBC Lowers Price Target on HCA Healthcare to $376 From $384, Keeps Outperform Rating
KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)
Barclays Remains a Buy on HCA Healthcare (HCA)
Research Alert: Admissions Growth Remains Healthy As Hca Healthcare Beats Estimates
Wolfe Research Adjusts HCA Healthcare Price Target to $355 From $348
HCA Healthcare Analyst Ratings
Baird Downgrades HCA Healthcare(HCA.US) to Hold Rating, Cuts Target Price to $336
Barclays Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $366
Barclays Sticks to Their Buy Rating for HCA Healthcare (HCA)
HCA Healthcare Analyst Ratings
BofA Securities Maintains HCA Healthcare(HCA.US) With Buy Rating
HCA Healthcare (HCA) Receives a Buy From Bank of America Securities
Cantor Fitzgerald Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $405
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call